SA
CHGCF logo
Chugai Pharmaceutical Co., Ltd.(CHGCF)
Closing price · checked 10:23 PM ETAbout this dataData status
$44.52▼-1.30 (-2.84%)
Extended:$45.82+1.30 (+2.92%)· 10:23 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average (VIX 24.6)

Overview →

Chugai Pharmaceutical Co., Ltd. (CHGCF)

R&D to Revenue

14.91%

Fiscal year · Period ending:

CHGCF logo

CHGCF R&D to Revenue

Latest reported14.91%
CHGCF FY R&D/Revenue (0.00% → 14.91%)
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

CHGCF r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Chugai Pharmaceutical Co., Ltd. R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
14.9131%
15.0984%
14.8253%
11.7751%
13.1308%
14.8169%
15.2631%
16.2008%
16.6266%
16.7813%
16.4023%
17.5206%
17.5318%
17.2246%
14.9541%
14.4139%
12.8955%
16.2799%
15.7314%
16.7456%
15.301%
16.3454%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.